ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,302, issued on July 28, was assigned to Genentech Inc. (South San Francisco, Calif.).

"Uses of IL-13 antagonists for treating atopic dermatitis" was invented by ChinYu Lin (South San Francisco, Calif.), Theodore A. Omachi (South San Francisco, Calif.), Ryan P. Owen (South San Francisco, Calif.), Karl Yen (South San Francisco, Calif.), Yanan Zheng (Cupertino, Calif.) and Kendra Debusk (New Hope, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Uses of IL-13 antagonists for treating atopic dermatitis are provided. Also provided are methods of treating atopic dermatitis and methods of reducing the severity of atopic dermatitis by administering IL-13 ...